The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $60.14

Today's change+0.14 +0.23%
Updated December 24 1:00 PM EST. Delayed by at least 15 minutes.
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $60.14

Today's change+0.14 +0.23%
Updated December 24 1:00 PM EST. Delayed by at least 15 minutes.

Magellan Health Inc up (U.S.)$0.14

Magellan Health Inc closed up Wednesday by (U.S.)$0.14 or 0.23% to (U.S.)$60.14. Over the last five days, shares have gained 1.30%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 10.15% during the last year.

Key company metrics

  • Open(U.S.) $60.10
  • Previous close(U.S.) $60.00
  • High(U.S.) $60.80
  • Low(U.S.) $59.92
  • Bid / Ask-- / --
  • YTD % change+0.38%
  • Volume61,014
  • Average volume (10-day)195,850
  • Average volume (1-month)167,090
  • Average volume (3-month)191,571
  • 52-week range(U.S.) $52.37 to (U.S.) $63.81
  • Beta0.66
  • Trailing P/E21.85×
  • P/E 1 year forward22.98×
  • Forward PEG1.15×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.75
Updated December 24 1:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.10%Sector:HealthcareIndustry:Managed Health Care
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue9238889661,008
Total other revenue--------
Total revenue9238889661,008
Gross profit49357149
Total cost of revenue874853896959
Total operating expense898876916980
Selling / general / administrative--------
Research & development--------
Depreciation / amortization24222021
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income25125128
Interest income (expense), net non-operating-3-2-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax22115028
Income after tax2642418
Income tax, total-362610
Net income2752618
Total adjustments to net income--------
Net income before extra. items2752618
Minority interest111--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2752618
Inc. avail. to common incl. extra. items2752618
Diluted net income2752618
Dilution adjustment0----0
Diluted weighted average shares27282828
Diluted EPS excluding extraordinary itemsvalue per share1.000.180.920.66
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.000.180.920.66